Thus, the present study demonstrated that KOR agonists provided neuroprotective effects against AD brain damage in APP/PS1 mice, which was at least partially mediated by inhibition of the Ca2+/CaMKII/CREB signaling pathway. This evidence concerns the gene CREB1 and Alzheimer disease.